Skip to main content

Market Overview

KemPharm (NYSE: KMPH)

8.60 -0.18 (-2.05%)

Analyst Ratings

DateResearch FirmActionCurrentPT
4/09/21HC Wainwright & Co.MaintainsNeutral10.0
3/04/21HC Wainwright & Co.DowngradesNeutral12.0
1/25/21Roth CapitalInitiates Coverage OnBuy28.0
5/20/20HC Wainwright & Co.ReiteratesBuy1.5
11/20/19H.C. WainwrightReiteratesBuy2.5
9/05/19Roth CapitalDowngradesNeutral1.1
6/19/19H.C. WainwrightInitiates Coverage OnBuy3.0
5/23/18Janney CapitalInitiates Coverage OnBuy17.0
2/26/18Canaccord GenuityMaintainsBuy11.0
12/20/16Canaccord GenuityAssumesBuy9.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter